AI Detects Hidden Brain Damage in Multiple Sclerosis, Offering New Hope

Researchers at the University of Buffalo have pioneered an artificial intelligence method capable of detecting subtle brain lesions that standard MRI scans have historically missed. This significant advancement promises to revolutionize the diagnosis and treatment of multiple sclerosis (MS), offering new hope to those affected by the chronic autoimmune disease.

MS affects the central nervous system by attacking the myelin sheath that protects nerve fibers, disrupting the transmission of nerve impulses. While traditional MRI primarily visualizes changes in the brain's white matter, lesions in the gray matter, believed to play a crucial role in disease progression and disability, have often remained undetected. The new AI algorithm analyzes multiple MRI scans simultaneously, identifying minute differences imperceptible to the human eye.

Published in "Communications Medicine," the study utilized the AI to examine scans from over 700 MS patients, uncovering more than 11,000 previously hidden lesions in the gray matter. "This discovery could have a major impact on clinical practice," the authors stated. "More precise monitoring of brain changes would allow doctors to better understand the disease's course, recognize its progression earlier, and more objectively assess the effectiveness of existing and future drugs."

For decades, pathologists have confirmed the existence of these lesions in post-mortem brain tissue, but technology had not allowed for reliable detection in living patients. The advancement of AI now opens the door to integrating this crucial information into everyday medical practice. While a cure for MS remains elusive, recent years have seen progress in therapies that slow disease progression and alleviate symptoms. This new AI capability suggests future treatments could be even more effective, providing physicians with a clearer view of the neurological changes occurring during the disease.

“

This discovery could have a major impact on clinical practice. More precise monitoring of brain changes would allow doctors to better understand the disease's course, recognize its progression earlier, and more objectively assess the effectiveness of existing and future drugs.